All Curated Mutation Sites in SARS-CoV-2

Back to Mutation Home

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in SARS-CoV-2 related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Furin cleavage site

Methyltransferase

Non-coding region

Keyword: COVID-19-36733340

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	36733340	H49Y	S	S	COVID-19	R L	View
2	36733340	L54F	S	S	COVID-19	R L	View
3	36733340	N74K	S	S	COVID-19	R L	View
4	36733340	D80Y	S	S	COVID-19	R L	View
5	36733340	G142A	S	S	COVID-19	R L	View
6	36733340	A222V	S	S	COVID-19	R L	View
7	36733340	G261R	S	S	COVID-19	R L	View
8	36733340	S943T	S	S	COVID-19	R L	View
9	36733340	D614G	S	S	COVID-19	R L	View
10	36733340	D614A	S	S	COVID-19	R L	View
11	36733340	V622F	S	S	COVID-19	R L	View
12	36733340	Q677H	S	S	COVID-19	R L	View
13	36733340	S813N	S	S	COVID-19	R L	View
14	36733340	A890T	S	S	COVID-19	R L	View
15	36733340	A1078S	S	S	COVID-19	R L	View
16	36733340	T1117I	S	S	COVID-19	R L	View
17	36733340	C840V	S	S	COVID-19	R L	View
18	36733340	A846V	S	S	COVID-19	R L	View
19	36733340	G446V	RBD	S	COVID-19	R L	View
20	36733340	G181V	NTD	S	COVID-19	R L	View
21	36733340	R102S	NTD	S	COVID-19	R L	View

Contents
Description

The table shows all curated mutation sites of SARS-CoV-2 in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.